author-photo

Kalpana Shah

24

Papers

276

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.

2020
Show All
- Source
- Cite
- Save
Citations (7)
Multispecific, Multivalent Antibody‐Based Molecules Engineered on the DART® and TRIDENTTM Platforms

2020 Current protocols in immunology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 2288: Investigational CD25 x CTLA-4 bispecific DART® molecule for depletion of tumor infiltrating Tregs via an enhanced Fc-dependent effector mechanism

2020 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (36)
Abstract 3637: Co-targeting of PD-1 and CTLA-4 inhibitory pathways with bispecific DART® and TRIDENT™ molecules

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3642: Tumor-antigen expression-dependent activation of the CD137 costimulatory pathway by bispecific DART® proteins

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Molécules bispécifiques présentant une immunoréactivité par rapport à pd-1 et à ctla-4 et leurs procédés d'utilisation

2016
Show All
- Source
- Cite
- Save
Citations (0)
Dianticorps monovalents bispécifiques capables de se lier à b7-h3 et à cd3 et leurs utilisations

2016
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2464: DART® molecules with enhanced DR5 agonistic activity for improved cancer cell cytotoxicity

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)